David E. Goel's Net Worth
$505 Million
Who is David E. Goel?
David E. Goel has an estimated net worth of $505 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, ACELYRIN, Inc., Aura Biosciences, Inc., Zentalis Pharmaceuticals, Inc., and POPULAR INC.
SEC CIK
David E. Goel's CIK is 0001548144
Past Insider Trading and Trends
2019 was David E. Goel's most active year for acquiring shares with 4 total transactions. David E. Goel's most active month to acquire stocks was the month of April. 2014 was David E. Goel's most active year for disposing of shares, totalling 10 transactions. David E. Goel's most active month to dispose stocks was the month of February. 2023 saw David E. Goel paying a total of $121,901,600.00 for 15,654,735 shares, this is the most they've acquired in one year. In 2020 David E. Goel cashed out on 4,217,101 shares for a total of $138,753,176.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.15% | -806.00K |
$39.99 | -$32,228,826.74 | 12.31M |
Mar 8 - Mar 10
| |||
Form 4
|
∞
| 1.5K |
—
|
—
| 1.5K |
Feb 15
| |||
Form 4
| -13.23% | -2.00M |
$40.00 | -$80,000,000.00 | 13.12M |
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| -12.79% | -2.22M |
$26.50 | -$58,753,176.50 | 15.12M |
Jan 24
| |||
Form 4
|
∞
| 17.33M |
—
|
—
| 17.33M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACELYRIN, Inc. (SLRN) Snapshot price: $7.928
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9.33M |
—
|
—
| 9.33M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aura Biosciences, Inc. (AURA) Snapshot price: $8.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.09% | 1.56M |
$9.00 | $14,040,000.00 | 6.92M |
Nov 9
| |||
Form 4
| +30.39% | 1.25M |
$12.00 | $15,000,000.00 | 5.36M |
Dec 5
| |||
Form 4
| +176.68% | 4.11M |
$14.00 | $24,990,000.00 | 6.44M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $11.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.74% | 4.76M |
$22.66 | $107,861,600.00 | 13.96M |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
POPULAR INC (BPOP) Snapshot price: $83.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +19.94% | 2.13K |
—
|
—
| 12.83K |
May 8
| |||
Form 4
| +28.89% | 2.34K |
—
|
—
| 10.45K |
May 23
| |||
Form 4
| +71.21% | 3.32K |
—
|
—
| 7.97K |
Apr 26
| |||
Form 4
| +30.04% | 1.06K |
—
|
—
| 4.59K |
May 28
| |||
Form 4
| +47.29% | 1.13K |
—
|
—
| 3.53K |
Jun 4
| |||
Form 4
| -100.00% | -466.18K |
$28.88 | -$13,464,295.04 |
0
|
May 14 - May 15
| |||
Form 4
| -68.20% | -1.00M |
$27.64 | -$27,638,000.00 | 466.18K |
Jan 28 - Jan 30
| |||
Form 4
| +96.24% | 1.18K |
—
|
—
| 2.4K |
May 28
| |||
Form 4
|
∞
| 1.22K |
—
|
—
| 1.22K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||